ArticleMolecular biotechnology2026

Data-Driven Discovery of a Key Regulator Cyclin A2 as a Promising Therapeutic Target in Hormone-Sensitive Cancers.

Suvitha Anbarasu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.